Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 91

1.

Comparison of safety and periprocedural complications of transfemoral aortic valve replacement in local anesthesia in minimalist versus complete heart team.

Droppa M, Borst O, Katzenberger T, Krause R, Grasshoff C, Gawaz M, Geisler T.

EuroIntervention. 2019 Jan 15. pii: EIJ-D-18-00795. doi: 10.4244/EIJ-D-18-00795. [Epub ahead of print]

2.

Relative survival potential of platelets is associated with platelet CXCR4/CXCR7 surface exposure and functional recovery following STEMI.

Rath D, Chatterjee M, Meyer L, Tekath N, Olma C, Krumm P, Adams C, Borst O, Müller K, Droppa M, Nikolaou K, Riethmüller J, Gawaz M, Geisler T.

Atherosclerosis. 2018 Nov;278:269-277. doi: 10.1016/j.atherosclerosis.2018.10.008. Epub 2018 Oct 6.

PMID:
30342381
3.

Previous TAVR in patients undergoing percutaneous edge-to-edge mitral valve repair (PMVR) affects improvement of MR.

Patzelt J, Ulrich M, Becker A, Müller KAL, Jorbenadze R, Droppa M, Zhang W, Mandel S, Habel L, Lausberg H, Pöss J, Geisler T, Borst O, Rosenberger P, Schlensak C, Gawaz M, Schreieck J, Seizer P, Langer HF.

PLoS One. 2018 Oct 19;13(10):e0205930. doi: 10.1371/journal.pone.0205930. eCollection 2018.

4.

Clinical and economical impact of the presence of an extended heart team throughout the balloon-expandable transcatheter aortic valve implantation procedure.

Droppa M, Borst O, Katzenberger T, Krause R, Bramlage K, Bramlage P, Lausberg HF, Schlensak C, Grasshoff C, Gawaz M, Geisler T.

Clin Res Cardiol. 2018 Aug 24. doi: 10.1007/s00392-018-1359-3. [Epub ahead of print]

PMID:
30167808
5.

Functional Relevance of the Anaphylatoxin Receptor C3aR for Platelet Function and Arterial Thrombus Formation Marks an Intersection Point Between Innate Immunity and Thrombosis.

Sauter RJ, Sauter M, Reis ES, Emschermann FN, Nording H, Ebenhöch S, Kraft P, Münzer P, Mauler M, Rheinlaender J, Madlung J, Edlich F, Schäffer TE, Meuth SG, Dürschmied D, Geisler T, Borst O, Gawaz M, Kleinschnitz C, Lambris JD, Langer HF.

Circulation. 2018 Oct 16;138(16):1720-1735. doi: 10.1161/CIRCULATIONAHA.118.034600. Erratum in: Circulation. 2019 Jan 15;139(3):e8.

PMID:
29802205
6.

Individualized antithrombotic therapy in high-risk cardiovascular patients.

Tegtmeyer R, Borst O, Gawaz M, Rath D.

Per Med. 2018 May 1;15(3):223-236. doi: 10.2217/pme-2017-0081. Epub 2018 May 25.

PMID:
29798711
7.

Identification of key lipids critical for platelet activation by comprehensive analysis of the platelet lipidome.

Peng B, Geue S, Coman C, Münzer P, Kopczynski D, Has C, Hoffmann N, Manke MC, Lang F, Sickmann A, Gawaz M, Borst O, Ahrends R.

Blood. 2018 Aug 2;132(5):e1-e12. doi: 10.1182/blood-2017-12-822890. Epub 2018 May 21.

8.

Inhibitory mechanisms of very low-dose rivaroxaban in non-ST-elevation myocardial infarction.

Borst O, Münzer P, Alnaggar N, Geue S, Tegtmeyer R, Rath D, Droppa M, Seizer P, Heitmeier S, Heemskerk JWM, Jennings LK, Storey RF, Angiolillo DJ, Rocca B, Spronk H, Ten Cate H, Gawaz M, Geisler T.

Blood Adv. 2018 Mar 27;2(6):715-730. doi: 10.1182/bloodadvances.2017013573.

9.

PDK1 governs thromboxane generation and thrombosis in platelets by regulating activation of Raf1 in the MAPK pathway.

Manne BK, Münzer P, Badolia R, Walker-Allgaier B, Campbell RA, Middleton E, Weyrich AS, Kunapuli SP, Borst O, Rondina MT.

J Thromb Haemost. 2018 Jun;16(6):1211-1225. doi: 10.1111/jth.14005. Epub 2018 May 8.

PMID:
29575487
10.

Ceramidase critically affects GPVI-dependent platelet activation and thrombus formation.

Münzer P, Mittelstädt S, Geue S, Manke MC, Walker-Allgaier B, Lang F, Gawaz M, Borst O.

Biochem Biophys Res Commun. 2018 Feb 12;496(3):792-798. doi: 10.1016/j.bbrc.2018.01.155. Epub 2018 Feb 1.

PMID:
29395079
11.

Antithrombotic Therapy After TAVR.

Geisler T, Droppa M, Muller K, Borst O.

Curr Vasc Pharmacol. 2018;16(5):437-445. doi: 10.2174/1570161116666180117145015.

PMID:
29345593
12.

Targeted antiplatelet therapy: novel treatment options for ischaemic heart disease.

Gawaz M, Borst O.

Eur Heart J. 2018 Jan 7;39(2):117-118. doi: 10.1093/eurheartj/ehx559. No abstract available.

PMID:
29029141
13.

Extracellular Cyclophilin A Augments Platelet-Dependent Thrombosis and Thromboinflammation.

von Ungern-Sternberg SNI, Vogel S, Walker-Allgaier B, Geue S, Maurer A, Wild AM, Münzer P, Chatterjee M, Heinzmann D, Kremmer E, Borst O, Loughran P, Zernecke A, Neal MD, Billiar TR, Gawaz M, Seizer P.

Thromb Haemost. 2017 Nov;117(11):2063-2078. doi: 10.1160/TH17-01-0067. Epub 2017 Nov 30.

14.

CK2β regulates thrombopoiesis and Ca2+-triggered platelet activation in arterial thrombosis.

Münzer P, Walker-Allgaier B, Geue S, Langhauser F, Geuss E, Stegner D, Aurbach K, Semeniak D, Chatterjee M, Gonzalez Menendez I, Märklin M, Quintanilla-Martinez L, Salih HR, Litchfield DW, Buchou T, Kleinschnitz C, Lang F, Nieswandt B, Pleines I, Schulze H, Gawaz M, Borst O.

Blood. 2017 Dec 21;130(25):2774-2785. doi: 10.1182/blood-2017-05-784413. Epub 2017 Sep 19.

15.

ADPase CD39 Fused to Glycoprotein VI-Fc Boosts Local Antithrombotic Effects at Vascular Lesions.

Degen H, Borst O, Ziegler M, Mojica Munoz AK, Jamasbi J, Walker B, Göbel S, Fassbender J, Adler K, Brandl R, Münch G, Lorenz R, Siess W, Gawaz M, Ungerer M.

J Am Heart Assoc. 2017 Jul 27;6(8). pii: e005991. doi: 10.1161/JAHA.117.005991.

16.

Impact of Intravenous P2Y12-Receptor Inhibition with Cangrelor in Patients Presenting with Acute Coronary Syndrome and Cardiogenic Shock - a Case Series.

Droppa M, Borst O, Rath D, Müller K, Gawaz M, Bhatt DL, Geisler T.

Cell Physiol Biochem. 2017;42(4):1336-1341. doi: 10.1159/000478962. Epub 2017 Jul 13.

17.

Involvement Of Vascular Aldosterone Synthase In Phosphate-Induced Osteogenic Transformation Of Vascular Smooth Muscle Cells.

Alesutan I, Voelkl J, Feger M, Kratschmar DV, Castor T, Mia S, Sacherer M, Viereck R, Borst O, Leibrock C, Gawaz M, Kuro-O M, Pilz S, Tomaschitz A, Odermatt A, Pieske B, Wagner CA, Lang F.

Sci Rep. 2017 May 17;7(1):2059. doi: 10.1038/s41598-017-01882-2.

18.

Histopathological and Immunological Characteristics of Tachycardia-Induced Cardiomyopathy.

Mueller KAL, Heinzmann D, Klingel K, Fallier-Becker P, Kandolf R, Kilias A, Walker-Allgaier B, Borst O, Kumbrink J, Kirchner T, Langer H, Geisler T, Schreieck J, Gramlich M, Gawaz M, Seizer P.

J Am Coll Cardiol. 2017 May 2;69(17):2160-2172. doi: 10.1016/j.jacc.2017.02.049.

19.

Regulation of oxidized platelet lipidome: implications for coronary artery disease.

Chatterjee M, Rath D, Schlotterbeck J, Rheinlaender J, Walker-Allgaier B, Alnaggar N, Zdanyte M, Müller I, Borst O, Geisler T, Schäffer TE, Lämmerhofer M, Gawaz M.

Eur Heart J. 2017 Jul 1;38(25):1993-2005. doi: 10.1093/eurheartj/ehx146.

PMID:
28431006
20.

Doxepin inhibits GPVI-dependent platelet Ca2+ signaling and collagen-dependent thrombus formation.

Geue S, Walker-Allgaier B, Eißler D, Tegtmeyer R, Schaub M, Lang F, Gawaz M, Borst O, Münzer P.

Am J Physiol Cell Physiol. 2017 Jun 1;312(6):C765-C774. doi: 10.1152/ajpcell.00262.2016. Epub 2017 Apr 12.

Supplemental Content

Support Center